- Home
- RDZN vs CELU Comparison
RDZN vs CELU Comparison
Compare RDZN & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDZN
- CELU
- Stock Information
- Founded
- RDZN 2015
- CELU 2016
- Country
- RDZN United States
- CELU United States
- Employees
- RDZN 308
- CELU N/A
- Industry
- RDZN Blank Checks
- CELU Biotechnology: Pharmaceutical Preparations
- Sector
- RDZN Finance
- CELU Health Care
- Exchange
- RDZN Nasdaq
- CELU Nasdaq
- Market Cap
- RDZN 74.5M
- CELU 64.3M
- IPO Year
- RDZN N/A
- CELU N/A
- Fundamental
- Price
- RDZN $0.99
- CELU $2.32
- Analyst Decision
- RDZN Strong Buy
- CELU Strong Buy
- Analyst Count
- RDZN 2
- CELU 1
- Target Price
- RDZN $5.00
- CELU $6.00
- AVG Volume (30 Days)
- RDZN 214.0K
- CELU 130.7K
- Earning Date
- RDZN 11-12-2025
- CELU 08-29-2025
- Dividend Yield
- RDZN N/A
- CELU N/A
- EPS Growth
- RDZN N/A
- CELU N/A
- EPS
- RDZN N/A
- CELU N/A
- Revenue
- RDZN $46,230,126.00
- CELU $44,590,000.00
- Revenue This Year
- RDZN $38.45
- CELU $23.29
- Revenue Next Year
- RDZN $66.38
- CELU N/A
- P/E Ratio
- RDZN N/A
- CELU N/A
- Revenue Growth
- RDZN N/A
- CELU 4.45
- 52 Week Low
- RDZN $0.68
- CELU $1.00
- 52 Week High
- RDZN $2.99
- CELU $5.22
- Technical
- Relative Strength Index (RSI)
- RDZN 45.76
- CELU 37.21
- Support Level
- RDZN $0.93
- CELU $2.02
- Resistance Level
- RDZN $1.00
- CELU $2.53
- Average True Range (ATR)
- RDZN 0.06
- CELU 0.30
- MACD
- RDZN 0.00
- CELU -0.14
- Stochastic Oscillator
- RDZN 55.63
- CELU 15.08
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.